Skip to main content

Table 1 Baseline characteristics for women enrolled in PREGACT trial in Malawi

From: Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial

Characteristic

Overall

AL

ASAQ

DHAPQ

Maternal age (years), median (IQR)

20.0 (18.0-24.0)

20.0 (18.0-24.0)

20.0 (18.0-25.0)

20.0 (19.5-24.0)

Gestation age (weeks), median (IQR)

21.0 (18.0-25.0)

21.0 (18.0-25.0)

21.0(18.0-25.0)

21.0 (18.0-24.0)

Haemoglobin(g/dl), mean (SD)

10.1 (1.3)

10.2 (1.4)

10.0 (1.3)

10.1 (1.3)

Primigravida, n (%)

444 (51.1)

144 (49.8)

144 (49.7)

156 (53.8)

Trimester

 Second, n (%)

730 (83.9)

242 (83.4)

244 (84.1)

244 (84.1)

 Third, n (%)

140 (16.1)

48 (16.6)

46 (15.9)

46 (15.9)

 Bed net use, n (%)

202 (23.2)

65 (22.4)

67 (23.1)

70 (24.1)